43 results on '"van Hulst, Karen"'
Search Results
2. Predicting non‐response to intraglandular botulinum neurotoxin A injections for drooling in children with neurodevelopmental disabilities
3. Comparing the evidence for botulinum neurotoxin injections in paediatric anterior drooling: a scoping review
4. Long-term effects of submandibular gland excision on drooling in children with neurodevelopmental disorders: A cross-sectional study
5. The medium to long-term effects of two-duct ligation for excessive drooling in neurodisabilities, a cross-sectional study
6. Speech‐language profiles in the context of cognitive and adaptive functioning in SATB2 ‐associated syndrome
7. Dysphagia limit in children with cerebral palsy aged 4 to 12 years
8. Surgery versus botulinum neurotoxin A to reduce drooling and improve daily life for children with neurodevelopmental disabilities: a randomized controlled trial
9. Posterior drooling in children with cerebral palsy and other neurodevelopmental disorders
10. Repeated onabotulinum neurotoxin A injections for drooling in children with neurodisability
11. Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy
12. An evaluation of predictors for success of two-duct ligation for drooling in neurodisabilities
13. Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities
14. Unsuccessful submandibular duct surgery for anterior drooling: Surgical failure or parotid gland salivation?
15. Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities
16. Effectiveness of submandibular duct relocation in 91 children with excessive drooling: A prospective cohort study
17. Reliability, construct validity and usability of the Eating and Drinking Ability Classification System (EDACS) among Dutch children with Cerebral Palsy
18. Early speech development in Koolen de Vries syndrome limited by oral praxis and hypotonia
19. Negative effects of submandibular botulinum neurotoxin A injections on oral motor function in children with drooling due to central nervous system disorders
20. The impact of submandibular duct relocation on drooling and the well-being of children with neurodevelopmental disabilities
21. Diagnosis and Management of Drooling in Children With Progressive Dystonia
22. Development of oral motor behavior related to the skill assisted spoon feeding
23. Children With Central and Peripheral Neurologic Disorders Have Distinguishable Patterns of Dysphagia on Videofluoroscopic Swallow Study
24. Accurate assessment of drooling severity with the 5-minute drooling quotient in children with developmental disabilities
25. What could predict effectiveness of Botulinum Toxin to treat drooling: A search for evidence of discriminatory factors on the level of body functions or structures
26. Clinical practice
27. Does Motor Performance Matter in Botulinum Toxin Efficacy for Drooling?
28. Efficacy and Duration of Botulinum Toxin Treatment for Drooling in 131 Children
29. Botulinum toxin versus submandibular duct relocation for severe drooling
30. Thickened saliva after effective management of drooling with botulinum toxin A
31. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control?
32. Drooling in children with cerebral palsy: a qualitative method to evaluate parental perceptions of its impact on daily life, social interaction, and self-esteem
33. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care
34. Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling
35. The Treatment of Posterior Drooling by Botulinum Toxin in a Child with Cerebral Palsy
36. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series
37. Pancreatic cancer in rats and hamsters does not induce IAPP-related hyperglycaemia
38. Biologically active human islet amyloid polypeptide/amylin in transgenic mice
39. Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus
40. Human Islet Amyloid Polypeptide Accumulates at Similar Sites in Islets of Transgenic Mice and Humans
41. Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice
42. IAPP/amylin transgenic mice as an in vivo modelsystem for type-2 diabetes mellitus?
43. Uridine branch acceptor is acis-acting element involved in regulation of the alternative processing of calcitonin/CGRP-I pre-mRNA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.